Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J3316 Injection., triptorelin x-ray 3.75 milligrams

J Codes (Drugs)

Also known as: triptorelin XR, extended-release triptorelin, long-acting GnRH agonist

Triptorelin extended-release 3.75 milligram injection is a long-acting gonadotropin-releasing hormone agonist for prostate cancer and endometriosis.

In Plain Language

long-lasting hormone suppression injection; prostate cancer medication

Clinical Context

Indicated for advanced prostate cancer requiring sustained hormone suppression. Extended-release formulation allows quarterly dosing versus more frequent standard triptorelin. Used in endometriosis and precocious puberty.

RVU Information

CPT J3316 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

OncologyUrologyGynecology

Frequently Asked Questions

What is CPT code J3316?

CPT J3316 (Injection., triptorelin x-ray 3.75 milligrams) is a J Codes (Drugs) code. Triptorelin extended-release 3.75 milligram injection is a long-acting gonadotropin-releasing hormone agonist for prostate cancer and endometriosis.

How is J3316 administered?

CPT J3316 is administered by a healthcare provider, typically via injection or infusion. Indicated for advanced prostate cancer requiring sustained hormone suppression. Extended-release formulation allows quarterly dosing versus more frequent standard triptorelin. Used in endometriosis and precocious puberty. It is used by Oncology, Urology, Gynecology.

When is CPT J3316 used?

Indicated for advanced prostate cancer requiring sustained hormone suppression. Extended-release formulation allows quarterly dosing versus more frequent standard triptorelin. Used in endometriosis and precocious puberty.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.